Non pvc iv bags market

Non-PVC IV Bags Market, by Type (Single-chambered and Multi-chambered), by Material (Polypropylene (PP) IV Bag, Polyethylene IV Bag, Copolyester Ether IV Bag, Ethylene-vinyl Acetate (EVA) IV Bag, and Others), by Application (Chemotherapy, Targeted Drug Delivery, Glucose Injection, Sodium Chloride Injection, Electrolyte Injection, Nutrient Injection, and Others), by End User (Hospitals, Clinics, Emergency Service Centers, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Request Free Sample

Dec 2021
CMI4840
206 Pages
Excel & Pdf
Medical Devices

Summary

Three types of bags are commonly used for IV fluids, which include glass bottles, PVC bags, and non-PVC bags. Certain drugs such as some insulin preservatives, vitamins, and others can react with PVC bags. Non-PVC bags are similar to PVC bags, but they generally do not react, although it depends on the drug being used. They are convenient for handling and transportation. The non-PVC IV bags include polypropylene IV bags, polyethylene IV bags, ethylene-vinyl acetate (EVA) IV bags, copolyester ether IV bags, and others.

The global non-PVC IV bags market is estimated to be valued at US$ 1,805.6 million in 2021, and is expected to exhibit a CAGR of 9.5% during the forecast period (2021-2028).

Figure 1. Global Non-PVC IV Bags Market Share (%) in Terms of Value, by Type, 2021

Increasing prevalence of cancer is expected to drive the market growth during the forecast period.

Factors such as the rising prevalence of cancer are expected to drive the market growth during the forecast period, as chemotherapy involves administration of medications orally or through an intravenous (IV) route. For instance, according to the World Health Organization (WHO), cancer is the second leading cause of death in the world. The American Cancer Society estimated that over 1.7 million new cancer cases were diagnosed in the U.S. in 2019. Moreover, according to an article published by Cancer Research U.K., in March 2020, 367,000 new cancer cases are reported each year in the U.K.

Non-PVC IV Bags Market Report Coverage

Report Coverage	Details
Base Year:	2020	Market Size in 2021:	US$ 1,805.6 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2021 to 2028
Forecast Period 2021 to 2028 CAGR:	9.5%	2028 Value Projection:	US$ 3,409.4 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Type: Single-chambered, Multi-chambered By Material: Polypropylene (PP) IV Bag, Polyethylene IV Bag, Copolyester Ether IV Bag, Ethylene-vinyl Acetate (EVA) IV Bag, Others By Application: Chemotherapy, Targeted Drug Delivery, Glucose Injection, Sodium Chloride Solution, Electrolyte Injection, Nutrient Injection, Others By End User: Hospitals, Clinics, Emergency Service Centers, Ambulatory Surgical Centers, Others
Companies covered:	Renolit SE, Kraton Corporation, Shanghai Solve Care Co., Ltd., Shanghai Xin Gen Eco-Technologies Co., Ltd., PolyCine GmbH, Jiangxi Sanxin Medtec Co., Ltd., Sealed Air, Baxter, B. Braun Melsungen AG, Sichuan Kelun Pharmaceutical Co., Ltd., Fresenius Kabi AG, Otsuka Holdings Co., Ltd., Sartorius AG, Technoflex, and Huaren Pharmaceutical Co., Ltd.
Growth Drivers:	Rising prevalence of cancer Rising awareness regarding the use of non-PVC IV bags Rising healthcare expenditure and research and development activities
Restraints & Challenges:	High cost of the non-PVC IV bags Stringent government regulatory policies

Figure 2. Global Non-PVC IV Bags Market Share (%), by Material, 2021

Increasing product launches by the key players is expected to drive the market growth during the forecast period.

The increasing number of novel product launches by the key players is expected to drive the market growth during the forecast period. For instance, in April 2021, Fresenius Kabi, a global healthcare company, announced that it had introduced two new presentations of Heparin Sodium in ready-to-administer and convenient Freeflex IV bags in the U.S. Freeflex bags are made up of polyolefin, which are Di-ethylhexyl-phthalate (DEHP) plasticizer free and non PVC.

Global Non-PVC IV Bags Market– Impact of Coronavirus (COVID-19) Pandemic

Before COVID-19, the healthcare industry was shifting towards community wellness and population health while still economically dependent on expensive, invasive procedures, and treatments. Key players conducted their operations smoothly and were focused on implementing growth strategies such as product approval and acquisition in the global non-PVC IV bags market.

Due to COVID-19, lockdown or shutdown was imposed in several countries globally, which had a negative impact on the economy of the private healthcare sector globally. Furthermore, healthcare providers were facing challenges, in terms of additional manpower, equipment, consumables, and other resources, which are required to ensure safety in hospitals and provide treatment to patients with other diseases, and this has impacted the market negatively. Due to nationwide lockdowns, the supply chain was badly hampered. This caused problems in the transportation of non-PVC IV bags from one place to another.

Global Non-PVC IV Bags Market: Restraint

The major factor that hinder growth of the global non-PVC IV bags market include high cost of the non-PVC IV bags and stringent government regulatory policies.

Key Players

Major players operating in the global non-PVC IV bags market include Renolit SE, Kraton Corporation, Shanghai Solve Care Co., Ltd., Shanghai Xin Gen Eco-Technologies Co., Ltd., PolyCine GmbH, Jiangxi Sanxin Medtec Co., Ltd., Sealed Air, Baxter, B. Braun Melsungen AG, Sichuan Kelun Pharmaceutical Co., Ltd., Fresenius Kabi AG, Otsuka Holdings Co., Ltd., Sartorius AG, Technoflex, and Huaren Pharmaceutical Co., Ltd.

Table of Content

*Browse 46 market data tables and 42 figures on "Non-PVC IV Bags Market” - Global forecast to 2028

N/A

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global non-PVC IV bags market during the forecast period (2021-2028)?

The global non-PVC IV bags market size is estimated to be valued at US$ 1,805.6 million in 2021, and is expected to exhibit a CAGR of 9.5% between the forecast period (2021 and 2028).

What are the major factors driving the market growth?

Factors such as rising prevalence of cancer, rising awareness regarding the use of non-PVC IV bags and rising healthcare expenditure and research and development activities are expected to drive the growth of the market during forecast period.

Which is the leading type segment in the market?

Single-chambered type segment is the leading type segment in the market.

What are the key factors hampering growth of the market?

The major factors hampering growth of the market include high cost of the non-PVC IV bags and stringent government regulatory policies.

Which are the major players operating in the market?

Major players operating in the market include Renolit SE, Kraton Corporation, Shanghai Solve Care Co., Ltd., Shanghai Xin Gen Eco-Technologies Co., Ltd., PolyCine GmbH, Jiangxi Sanxin Medtec Co., Ltd., Sealed Air, Baxter, B. Braun Melsungen AG, Sichuan Kelun Pharmaceutical Co., Ltd., Fresenius Kabi AG, Otsuka Holdings Co., Ltd., Sartorius AG, Technoflex, and Huaren Pharmaceutical Co., Ltd.